Delivery Order SPE2DR25D2212-SPE2DR26FB9FC
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,061.39 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on October 27, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 28, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $11,796.04 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 27, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. The award represents a discrete delivery under AmerisourceBergen's broader contract portfolio supporting federal medical...
- The Defense Logistics Agency awarded a $69,558.28 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers....
- The Defense Logistics Agency awarded a $18,908.20 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. As a pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,043.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order, awarded on October 23, 2025, with no set-aside designation, represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $9,080.88 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,539.58 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitive, non-set-aside contract was executed on November 3, 2025, with an ultimate completion date of November 4, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award employs firm fixed-price pricing and represents a child...
- The Defense Logistics Agency (DLA) awarded a $8,634.89 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order, issued on October 30, 2025, supports the federal government's pharmaceutical supply needs through a competitive procurement process with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters location in...
- The Defense Logistics Agency awarded a $7,020.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Repatha 140 mg/ml SureClick auto-injectors. The delivery order, which represents a child contract under a larger vehicle, has an ultimate completion date of October 23, 2025. This non-set-aside award reflects a competitive procurement process for pharmaceutical supplies supporting military and federal healthcare systems. AmerisourceBergen, headquartered in...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9FCDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,709.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-set-aside competitive award reflects continued reliance on AmerisourceBergen's pharmaceutical distribution capabilities to support federal medical supply needs. The delivery order is set to conclude by November 6, 2025, with performance executed from the contractor's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery order operates under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains to support military healthcare programs and other federal health systems. The Repatha delivery represents the company's ongoing role as a critical vendor in the DLA's medical supply chain, supporting military and veteran healthcare initiatives through a flexible contracting mechanism that accommodates varying pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 11/5/25 |